Prestige Consumer Healthcare
Personal care products
Acquired Australian company Care Pharmaceuticals in 2013 and CB Fleet in 2017.

Overall

Owned USA
Rating D
About the Ratings
Prestige Consumer Healthcare Inc
USA

Company Assessment

(Last updated Sep 2024)
Prestige Consumer Healthcare Inc
Criticism
30/100 S&P Global ESG Score
This company received an S&P Global ESG Score of 30/100 in the Pharmaceuticals category of the S&P Global Corporate Sustainability Assessment, an annual evaluation of companies' sustainability practices (last updated 18 Nov 2022). The rankings are based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, environmental reporting, climate strategy, human rights and labour practices.
Information
CSR claims
This company has Corporate Social Responsibility claims on its website.
> About the Icons

Company Details

Type:
Public company
Founded:
1996
Revenue:
1 billion USD (2022)
Employees:
535 (2022)
Subsidiaries:
CB Fleet Company Inc
Personal health products
Acquired by Prestige Consumer Healthcare in 2017.
Care Pharmaceuticals Pty Ltd
Healthcare products
Established in Australia in 1986 and acquired by Prestige Brands in 2013.

Contact Details

Address:
Tarrytown, New York, USA
Website:
www.prestigebrands.com

Products / Brands

Care Pharmaceuticals
Murine Eye & Ear Care